MedCentral creating physician-facing

Despite major advances in contraception over the past several decades, responsibility for pregnancy prevention falls largely on women.1 Although currently available female contraceptives offer numerous reversible options with failure rates ranging from less than 1% to over 20%, many women have contraindications or discontinue use due to adverse effects.2 The consequences are global in scale.

For people with diabetes, cannabis use can exacerbate cardiovascular risk, destabilize blood glucose management, and undermine day‑to‑day medication adherence, according to recent reports by the American Diabetes Association (ADA).1 Citing the risk for cannabis hyperemesis syndrome (CHS) and related metabolic decompensation in response to accumulating evidence, the 2025 ADA Standards of Care in Diabetes added 2 new recommendations for clinicians: (1) Advise people with type 1 diabetes (T1D)...